Geoff Meacham
Stock Analyst at Citi
(4.85)
# 401
Out of 5,104 analysts
1265
Total ratings
58.3%
Success rate
14.6%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PFE Pfizer | Maintained: Hold | $27 → $30 | $30.00 | - | 79 | Nov 4, 2026 | |
| AMGN Amgen | Maintained: Hold | $405 → $465 | $461.26 | +0.81% | 52 | Nov 4, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $585 | $530.76 | +10.22% | 72 | Nov 3, 2026 | |
| ABBV AbbVie | Reiterated: Hold | $260 → $295 | $286.00 | +3.15% | 71 | Nov 2, 2026 | |
| ABOS Acumen Pharmaceuticals | Downgraded: Hold | $5 → $1 | $0.2344 | +326.62% | 14 | Nov 2, 2026 | |
| JAZZ Jazz Pharmaceuticals | Reiterated: Buy | $325 | $229.74 | +41.46% | 4 | Nov 2, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Hold | $740 → $825 | $973.36 | -15.24% | 64 | Nov 2, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $165 → $188 | $167.47 | +12.26% | 83 | Oct 30, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,600 → $1,650 | $1,409.38 | +17.07% | 103 | Oct 30, 2026 | |
| BIIB Biogen | Reiterated: Hold | $215 → $255 | $248.93 | +2.44% | 75 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $127.09 | +18.03% | 22 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $86.92 | +43.81% | 20 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $145 | $144.67 | +0.23% | 68 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $80 | $228.44 | -64.98% | 65 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 | $133.61 | +19.75% | 13 | Oct 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $39 | $29.20 | +33.56% | 22 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 → $8 | $9.68 | -17.36% | 8 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $19.65 | +179.90% | 4 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $93.29 | +7.19% | 19 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $19.90 | +176.38% | 5 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.69 | +155.86% | 2 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $182 | $140.24 | +29.78% | 15 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 | $43.98 | +68.26% | 8 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $19.86 | +151.76% | 5 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $70 | $61.71 | +13.43% | 75 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $66.40 | +5.42% | 29 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $75 | $68.12 | +10.10% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 | $266.17 | n/a | 33 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $0.5709 | n/a | 3 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $55.66 | n/a | 35 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $0.4594 | n/a | 8 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $49.99 | n/a | 8 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $9 | $10.77 | n/a | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $15.99 | n/a | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $14 | $2.44 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $60.81 | n/a | 1 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.5558 | n/a | 4 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $15 | $21.37 | n/a | 4 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $48.70 | n/a | 1 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.52 | n/a | 4 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $23 → $14 | $11.22 | n/a | 4 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $25 | $17.82 | n/a | 2 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $42.20 | n/a | 1 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $18 | $74.03 | n/a | 6 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $18.91 | n/a | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 → $2 | $3.50 | n/a | 3 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $16 | $2.60 | n/a | 2 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $80 → $150 | $601.32 | n/a | 15 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $49 | $62.31 | n/a | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $24 | $1.66 | n/a | 6 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $4 | $18.27 | n/a | 5 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $62 | $1.38 | n/a | 3 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $20 | $14.64 | n/a | 2 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $7.63 | n/a | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $49 → $75 | $8.21 | n/a | 10 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $0.92 | n/a | 1 | Jun 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $31.90 | n/a | 1 | Mar 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $2.51 | n/a | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $8.57 | n/a | 1 | Dec 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $22.08 | n/a | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $0.117 | n/a | 1 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $8.76 | n/a | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $49.41 | n/a | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €80.32 | €149.15 | n/a | 1 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 → $32 | $9.28 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $90 → $82 | $117.59 | n/a | 15 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $13 | $3.50 | n/a | 9 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $2.05 | n/a | 2 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $10.11 | n/a | 3 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 → $110 | $164.85 | n/a | 11 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $2.18 | n/a | 1 | Mar 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $42.89 | $11.41 | n/a | 6 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $105 | $159.89 | n/a | 8 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $20 → $8 | $30.13 | n/a | 2 | Sep 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $25 → $16 | $10.37 | n/a | 2 | Oct 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $60 → $90 | $31.20 | n/a | 5 | Dec 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.14 | n/a | 1 | Sep 17, 2012 |
Pfizer
Nov 4, 2026
Maintained: Hold
Price Target: $27 → $30
Current: $30.00
Upside: -
Amgen
Nov 4, 2026
Maintained: Hold
Price Target: $405 → $465
Current: $461.26
Upside: +0.81%
Vertex Pharmaceuticals
Nov 3, 2026
Reiterated: Buy
Price Target: $585
Current: $530.76
Upside: +10.22%
AbbVie
Nov 2, 2026
Reiterated: Hold
Price Target: $260 → $295
Current: $286.00
Upside: +3.15%
Acumen Pharmaceuticals
Nov 2, 2026
Downgraded: Hold
Price Target: $5 → $1
Current: $0.2344
Upside: +326.62%
Jazz Pharmaceuticals
Nov 2, 2026
Reiterated: Buy
Price Target: $325
Current: $229.74
Upside: +41.46%
Regeneron Pharmaceuticals
Nov 2, 2026
Reiterated: Hold
Price Target: $740 → $825
Current: $973.36
Upside: -15.24%
Gilead Sciences
Oct 30, 2026
Reiterated: Buy
Price Target: $165 → $188
Current: $167.47
Upside: +12.26%
Eli Lilly and Company
Oct 30, 2026
Reiterated: Buy
Price Target: $1,600 → $1,650
Current: $1,409.38
Upside: +17.07%
Biogen
Oct 29, 2026
Reiterated: Hold
Price Target: $215 → $255
Current: $248.93
Upside: +2.44%
Oct 29, 2026
Reiterated: Buy
Price Target: $150
Current: $127.09
Upside: +18.03%
Oct 27, 2026
Reiterated: Buy
Price Target: $125
Current: $86.92
Upside: +43.81%
Oct 27, 2026
Reiterated: Hold
Price Target: $145
Current: $144.67
Upside: +0.23%
Oct 27, 2026
Reiterated: Sell
Price Target: $80
Current: $228.44
Upside: -64.98%
Oct 19, 2026
Reiterated: Buy
Price Target: $160
Current: $133.61
Upside: +19.75%
Oct 16, 2026
Reiterated: Buy
Price Target: $32 → $39
Current: $29.20
Upside: +33.56%
Oct 16, 2026
Reiterated: Sell
Price Target: $7 → $8
Current: $9.68
Upside: -17.36%
Oct 15, 2026
Reiterated: Buy
Price Target: $55
Current: $19.65
Upside: +179.90%
Oct 15, 2026
Reiterated: Buy
Price Target: $100
Current: $93.29
Upside: +7.19%
Oct 15, 2026
Reiterated: Buy
Price Target: $55
Current: $19.90
Upside: +176.38%
Oct 15, 2026
Reiterated: Buy
Price Target: $12
Current: $4.69
Upside: +155.86%
Oct 15, 2026
Reiterated: Buy
Price Target: $182
Current: $140.24
Upside: +29.78%
Oct 15, 2026
Reiterated: Buy
Price Target: $74
Current: $43.98
Upside: +68.26%
Oct 15, 2026
Reiterated: Buy
Price Target: $50
Current: $19.86
Upside: +151.76%
Oct 13, 2026
Reiterated: Hold
Price Target: $70
Current: $61.71
Upside: +13.43%
Oct 12, 2026
Reiterated: Buy
Price Target: $70
Current: $66.40
Upside: +5.42%
May 7, 2026
Reiterated: Hold
Price Target: $75
Current: $68.12
Upside: +10.10%
Jun 10, 2024
Reiterated: Hold
Price Target: $170
Current: $266.17
Upside: n/a
Jun 6, 2024
Reiterated: Buy
Price Target: $22
Current: $0.5709
Upside: n/a
Jun 4, 2024
Reiterated: Buy
Price Target: $130
Current: $55.66
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: $17
Current: $0.4594
Upside: n/a
May 23, 2024
Reiterated: Buy
Price Target: $100
Current: $49.99
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $14 → $9
Current: $10.77
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $36
Current: $15.99
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $10 → $14
Current: $2.44
Upside: n/a
May 10, 2024
Reiterated: Buy
Price Target: $101
Current: $60.81
Upside: n/a
Mar 15, 2024
Rated: Hold
Price Target: n/a
Current: $0.5558
Upside: n/a
Dec 15, 2023
Downgraded: Hold
Price Target: $23 → $15
Current: $21.37
Upside: n/a
Oct 11, 2023
Reiterated: Sell
Price Target: n/a
Current: $48.70
Upside: n/a
Sep 29, 2023
Rated: Hold
Price Target: n/a
Current: $1.52
Upside: n/a
Sep 8, 2023
Downgraded: Hold
Price Target: $23 → $14
Current: $11.22
Upside: n/a
Jul 18, 2023
Reiterated: Buy
Price Target: $35 → $25
Current: $17.82
Upside: n/a
Mar 16, 2023
Reiterated: Buy
Price Target: $13
Current: $42.20
Upside: n/a
Mar 6, 2023
Reiterated: Buy
Price Target: $13 → $18
Current: $74.03
Upside: n/a
Feb 28, 2023
Reiterated: Hold
Price Target: $23
Current: $18.91
Upside: n/a
Feb 23, 2023
Downgraded: Sell
Price Target: $8 → $2
Current: $3.50
Upside: n/a
Feb 22, 2023
Reiterated: Hold
Price Target: $15 → $16
Current: $2.60
Upside: n/a
Feb 22, 2023
Reiterated: Sell
Price Target: $80 → $150
Current: $601.32
Upside: n/a
Feb 17, 2023
Initiated Coverage: Hold
Price Target: $49
Current: $62.31
Upside: n/a
Feb 16, 2023
Reiterated: Sell
Price Target: $2 → $24
Current: $1.66
Upside: n/a
Jun 8, 2022
Downgraded: Hold
Price Target: $12 → $4
Current: $18.27
Upside: n/a
May 18, 2022
Reiterated: Buy
Price Target: $75 → $62
Current: $1.38
Upside: n/a
May 17, 2022
Reiterated: Buy
Price Target: $28 → $20
Current: $14.64
Upside: n/a
Jan 13, 2022
Reiterated: Buy
Price Target: $60
Current: $7.63
Upside: n/a
Oct 8, 2021
Reiterated: Hold
Price Target: $49 → $75
Current: $8.21
Upside: n/a
Jun 8, 2021
Upgraded: Hold
Price Target: n/a
Current: $0.92
Upside: n/a
Mar 19, 2021
Reiterated: Buy
Price Target: $35
Current: $31.90
Upside: n/a
Jan 5, 2021
Reiterated: Buy
Price Target: $70
Current: $2.51
Upside: n/a
Dec 7, 2020
Reiterated: Buy
Price Target: $9
Current: $8.57
Upside: n/a
Nov 23, 2020
Initiated Coverage: Buy
Price Target: $21
Current: $22.08
Upside: n/a
Sep 8, 2020
Initiated Coverage: Buy
Price Target: $20
Current: $0.117
Upside: n/a
Jun 25, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $8.76
Upside: n/a
Feb 25, 2020
Downgraded: Hold
Price Target: $20 → $19
Current: $49.41
Upside: n/a
Feb 20, 2020
Reiterated: Hold
Price Target: €80.32
Current: €149.15
Upside: n/a
Dec 3, 2019
Initiated Coverage: Buy
Price Target: $27 → $32
Current: $9.28
Upside: n/a
May 3, 2019
Downgraded: Hold
Price Target: $90 → $82
Current: $117.59
Upside: n/a
May 2, 2019
Reiterated: Hold
Price Target: $13 → $13
Current: $3.50
Upside: n/a
Mar 29, 2019
Reiterated: Buy
Price Target: $27
Current: $2.05
Upside: n/a
Mar 29, 2019
Reiterated: Hold
Price Target: $8
Current: $10.11
Upside: n/a
Mar 28, 2019
Reiterated: Buy
Price Target: $103 → $110
Current: $164.85
Upside: n/a
Mar 11, 2019
Initiated Coverage: Buy
Price Target: $16
Current: $2.18
Upside: n/a
Feb 20, 2019
Rated: Buy
Price Target: $42.89
Current: $11.41
Upside: n/a
Sep 7, 2017
Rated: Buy
Price Target: $80 → $105
Current: $159.89
Upside: n/a
Sep 7, 2017
Rated: Sell
Price Target: $20 → $8
Current: $30.13
Upside: n/a
Oct 23, 2015
Downgraded: Sell
Price Target: $25 → $16
Current: $10.37
Upside: n/a
Dec 2, 2014
Downgraded: Hold
Price Target: $60 → $90
Current: $31.20
Upside: n/a
Sep 17, 2012
Downgraded: Hold
Price Target: n/a
Current: $14.14
Upside: n/a